|
Status |
Public on May 17, 2024 |
Title |
ChIP-seq of BRD4 of HCT116 cells treated with MZ1 or PDD00017273 |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
Targeted protein degradation is a groundbreaking modality in drug discovery ; however, the regulatory mechanisms are still not fully understood. Here, we identify cellular signaling pathways that modulate the targeted degradation of the anticancer target BRD4 and related hard-to-degrade targets BRD2/3 induced by CRL2VHL- or CRL4CRBN -based PROTACs. The chemicals identified as degradation enhancers include inhibitors of cellular signaling pathways such as poly-ADP ribosylation (PARG inhibitor PDD00017273), unfolded protein response (PERK inhibitor GSK2606414), and protein stabilization (HSP90 inhibitor luminespib). Mechanistically, PARG inhibition promotes TRIP12-mediated K29/K48-linked branched ubiquitylation of BRD4 by facilitating chromatin dissociation of BRD4 and formation of the BRD4–PROTAC–CRL2VHL ternary complex; by contrast, HSP90 inhibition promotes BRD4 degradation after the ubiquitylation step. Consequently, these signal inhibitors sensitize cells to the PROTAC-induced apoptosis. These results suggest that various cell-intrinsic signaling pathways spontaneously counteract chemically induced target degradation at multiple steps, which could be liberated by specific inhibitors.
|
|
|
Overall design |
BRD4 binding profiles in HCT116 cells treated with MZ1 and PDD00017273 were generated by ChIP-sequencing using illumina NextSeq 2000
|
|
|
Contributor(s) |
Ohtake F, Hattori N |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Apr 01, 2024 |
Last update date |
May 18, 2024 |
Contact name |
Naoko Hattori |
E-mail(s) |
naokohattori0514@gmail.com
|
Organization name |
Hoshi University
|
Department |
Department of Epigenomics
|
Street address |
2-4-41 Ebara, Shinagawa-ku
|
City |
Tokyo |
ZIP/Postal code |
142-8501 |
Country |
Japan |
|
|
Platforms (1) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA1094952 |